Vaxcyte prices public offerings and $500M convertible notes
Vaxcyte priced its public offerings of common stock and $500 million of convertible senior notes due 2032.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.